Lucier Gregory T's Form 4 filing

Maravai Lifesciences Holdings, Inc. (MRVI) · filed Dec 9, 2025

Accession no.: 0001251299-25-000004
Filed: Dec 9, 2025
Trade date: Dec 5-8, 2025
Filing delay: 4 days
Rule 10b5-1 plan: Not checked

Original on SEC EDGAR (opens in a new tab)

This filing lists 2 non-derivative transactions. Open-market purchases total $368.5K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
Owner	Relationship to the company
Lucier Gregory TCIK 0001251299	Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade date	Security	Transaction	Shares	Price	Value	Shares after	Ownership	Flags
Dec 5, 2025	Class A Common Stock	PPurchaseAcquired	+51,472	$3.70^F1	+$190,446.4	106,595	Direct
Dec 8, 2025	Class A Common Stock	PPurchaseAcquired	+48,528	$3.67^F2	+$178,097.76	155,123	Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.679 to $3.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Referenced by the price of 1 transaction in Table I.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.62 to $3.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)